Literature DB >> 28176245

Effect of annexin A7 suppression on the apoptosis of gastric cancer cells.

Weihua Ye1, Yong Li2, Liqiao Fan3, Qun Zhao3, Hufang Yuan3, Bibo Tan3, Zhidong Zhang3.   

Abstract

Understanding the molecular mechanism of gastric cancer cell apoptosis is pivotal for the development of precise therapies targeting this disease. In the present study, we examined the effects of annexin A7 inhibition on the apoptosis of gastric cancer cells and the growth of tumour xenografts in vivo. Expression of annexin A7 in BGC823 cells was suppressed by small interference RNA, and cells apoptosis was assessed by flow cytometry. The mechanism by which annexin A7 mediates apoptosis in BGC823 cells was explored by determining the expression of key apoptosis regulators. In addition, by suppressing annexin A7 in BGC823 cells with small hairpin RNA, we studied the effects of annexin A7 inhibition on in vivo tumour growth. Our results showed that inhibiting annexin A7 expression induced more than fivefold increase in BGC823 cell apoptosis in vitro. This was in concord with a significant decrease of Bcl-2 expression and increases of Bax, Caspase-3, and Caspase-9. The activities of caspase-3 and caspase-9 were increased by 2.95 ± 0.18 and 3.70 ± 0.33 times, respectively, upon the annexin A7 downregulation in BGC823 cells. Importantly, suppressing annexin A7 showed the same apoptotic mechanism in vivo and significantly inhibited the growth of BGC823 xenografts in mice. These data suggest that annexin A7 likely protects gastric cells from apoptosis and targeting it may represent a valuable strategy in future therapeutic development.

Entities:  

Keywords:  Annexin A7; Apoptosis; Gastric cancer; RNA interference

Mesh:

Substances:

Year:  2017        PMID: 28176245     DOI: 10.1007/s11010-016-2934-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  53 in total

1.  Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway.

Authors:  Z D Zhang; Y Li; Q Fan; B Zhao; B Tan; X F Zhao
Journal:  Neoplasma       Date:  2014       Impact factor: 2.575

2.  Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis.

Authors:  Ming-Zhong Sun; Shuqing Liu; Jianwu Tang; Zhiqiang Wang; Xiaolin Gong; Chengrong Sun; Frederic Greenaway
Journal:  Proteomics       Date:  2009-06       Impact factor: 3.984

3.  Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane.

Authors:  Tomomi Kuwana; Mason R Mackey; Guy Perkins; Mark H Ellisman; Martin Latterich; Roger Schneiter; Douglas R Green; Donald D Newmeyer
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

4.  ANX7, a candidate tumor suppressor gene for prostate cancer.

Authors:  M Srivastava; L Bubendorf; V Srikantan; L Fossom; L Nolan; M Glasman; X Leighton; W Fehrle; S Pittaluga; M Raffeld; P Koivisto; N Willi; T C Gasser; J Kononen; G Sauter; O P Kallioniemi; S Srivastava; H B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

5.  Down-regulation of ANXA7 decreases metastatic potential of human hepatocellular carcinoma cells in vitro.

Authors:  Mohammed Mohammed Ibrahim; Ming-Zhong Sun; Yuhong Huang; Mao Jun; Yanling Jin; Du Yue; Wang Jiasheng; Jun Zhang; Asma Saleem Qazi; Ken Sagoe; Jianwu Tang
Journal:  Biomed Pharmacother       Date:  2013-02-27       Impact factor: 6.529

6.  A network model of a cooperative genetic landscape in brain tumors.

Authors:  Markus Bredel; Denise M Scholtens; Griffith R Harsh; Claudia Bredel; James P Chandler; Jaclyn J Renfrow; Ajay K Yadav; Hannes Vogel; Adrienne C Scheck; Robert Tibshirani; Branimir I Sikic
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

7.  Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.

Authors:  Ajay K Yadav; Jaclyn J Renfrow; Denise M Scholtens; Hehuang Xie; George E Duran; Claudia Bredel; Hannes Vogel; James P Chandler; Arnab Chakravarti; Pierre A Robe; Sunit Das; Adrienne C Scheck; John A Kessler; Marcelo B Soares; Branimir I Sikic; Griffith R Harsh; Markus Bredel
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Dysregulation of the annexin family protein family is associated with prostate cancer progression.

Authors:  Wei Xin; Daniel R Rhodes; Collette Ingold; Arul M Chinnaiyan; Mark A Rubin
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

10.  Mutations of PIK3CA in gastric adenocarcinoma.

Authors:  Vivian Sze Wing Li; Chi Wai Wong; Tsun Leung Chan; Agnes Sze Wah Chan; Wei Zhao; Kent-Man Chu; Samuel So; Xin Chen; Siu Tsan Yuen; Suet Yi Leung
Journal:  BMC Cancer       Date:  2005-03-23       Impact factor: 4.430

View more
  7 in total

Review 1.  Annexin Animal Models-From Fundamental Principles to Translational Research.

Authors:  Thomas Grewal; Carles Rentero; Carlos Enrich; Mohamed Wahba; Carsten A Raabe; Ursula Rescher
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

2.  Prognostic roles of miR-124-3p and its target ANXA7 and their effects on cell migration and invasion in hepatocellular carcinoma.

Authors:  Honghai Wang; Jun Mao; Yuhong Huang; Jun Zhang; Lin Zhong; Ying Wu; He Huang; Jiayu Yang; Yuanyi Wei; Jianwu Tang
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

3.  Cyclin E and FGF8 are downstream cell growth regulators in distinct tumor suppressor effects of ANXA7 in hormone-resistant cancer cells of breast versus prostate origin.

Authors:  A Bera; X-M Leighton; H Pollard; M Srivastava
Journal:  Trends Cancer Res       Date:  2018

4.  ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L.

Authors:  Haiyan Liu; Dan Guo; Yuou Sha; Chenlu Zhang; Yijing Jiang; Lemin Hong; Jie Zhang; Yuwen Jiang; Ling Lu; Hongming Huang
Journal:  Aging (Albany NY)       Date:  2020-06-10       Impact factor: 5.682

5.  Leptin Receptor (LEPR) promotes proliferation, migration, and invasion and inhibits apoptosis in hepatocellular carcinoma by regulating ANXA7.

Authors:  He Huang; Jun Zhang; Fei Ling; Yuhong Huang; Min Yang; Yao Zhang; Yuanyi Wei; Qingqing Zhang; Honghai Wang; Lin Song; Ying Wu; Jiayu Yang; Jianwu Tang
Journal:  Cancer Cell Int       Date:  2021-01-04       Impact factor: 5.722

6.  Proteome Profiling of PMJ2-R and Primary Peritoneal Macrophages.

Authors:  Alexander L Rusanov; Peter M Kozhin; Olga V Tikhonova; Victor G Zgoda; Dmitry S Loginov; Adéla Chlastáková; Martin Selinger; Jan Sterba; Libor Grubhoffer; Nataliya G Luzgina
Journal:  Int J Mol Sci       Date:  2021-06-12       Impact factor: 5.923

7.  Annexin A7 and JNK knockdown suppress the lymphatic metastasis potential of hepatocellular carcinoma cells: Possible contributions of ATF2 and sequence-related lncRNA NONMMUT114121.1.

Authors:  Qi Deng; Huanxi Wang; Zhe Pan; Yanling Jin
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.